Leronlimab can/will create a new classification of
Post# of 152138

"Vaccines & Therapuetics"
Leronlimab has none of the drawbacks of each classification.
Add LL-PLS, vectoring ability & Roza's outstanding switch discovery.
If you treat as long as a vaccine.
Have none of therapuetic SAE's.
"monoclonial antibody" is vague.
How to medically profile LL ?
Create a new sub-class for it ??

